This five-day virtual experience will feature live and on-demand content with live case-based transmissions from around the globe, late-breaking clinical trials, focused innovation sessions, and countless opportunities to learn and engage with the brightest minds in interventional cardiovascular medicine.
“This year, TCT Connect has the potential to deliver high-quality education, training, and clinical science to more people than ever before,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF. “By expanding our educational footprint, we hope to share the research and discoveries presented at TCT to a larger, more diverse audience ultimately leading to improved care for people with heart disease.”
TCT Connect will include more than 100 hours of content airing on three channels (Main Arena, World Connect, and Innovation & E-Training), hundreds of abstracts and challenging cases that will be available on-demand, and a Virtual Exhibit Hall. The Program at a Glance can be found here: https://www.tctconnect.com/tct-program-glance/.
HOW TO REGISTER:
Attendees may register for free by visiting: https://www.crf.org/login-tctconnect2020-registration.
Media may register for press access at: https://www.tctconnect.com/tct-press-registration/.
Details on required press credentials can be found at: https://www.tctconnect.com/tct-press-policies-information/.
About CRF and TCT
The Cardiovascular Research Foundation (CRF) is one of the world’s leading nonprofit organizations specializing in interventional cardiology innovation, research, and education. CRF is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For nearly 30 years, CRF has helped pioneer medical advances and educated doctors on the latest treatments for heart disease. CRF is comprised of the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team.
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the premier educational meeting specializing in interventional cardiovascular medicine. Now in its 32nd year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.